Patents by Inventor Katarzyna Maresz

Katarzyna Maresz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11911349
    Abstract: A method for rapidly improving cardiovascular function, reducing arterial stiffness and reversing calcification of a blood vessel in a mammal comprising administering to the mammal an effective amount of vitamin K for a period of less than 6 months. Also a method for increasing endothelial nitric oxide production in mammals comprising administering to the mammal an effective amount of vitamin K for a period of less than 6 months. The vitamin K can be administered together with additional substances such as vitamin D.
    Type: Grant
    Filed: April 1, 2019
    Date of Patent: February 27, 2024
    Assignee: NATTOPHARMA AS
    Inventors: Stefan Chlopicki, Katarzyna Maresz, Anna Bar
  • Publication number: 20220160651
    Abstract: A method for rapidly improving cardiovascular function, reducing arterial stiffness and reversing calcification of a blood vessel in a mammal comprising administering to the mammal an effective amount of vitamin K for a period of 2 weeks to less than 6 months. Also a method for increasing endothelial nitric oxide production in mammals comprising administering to the mammal an effective amount of vitamin K for a period of 2 to 8 weeks. The vitamin K can be administered together with additional substances such as vitamin D.
    Type: Application
    Filed: March 10, 2020
    Publication date: May 26, 2022
    Inventors: Stefan CHLOPICKI, Katarzyna MARESZ, BAR Anna
  • Publication number: 20200289434
    Abstract: A method for rapidly improving cardiovascular function, reducing arterial stiffness and reversing calcification of a blood vessel in a mammal comprising administering to the mammal an effective amount of vitamin K for a period of 2 weeks to less than 6 months. Also a method for increasing endothelial nitric oxide production in mammals comprising administering to the mammal an effective amount of vitamin K for a period of 2 to 8 weeks. The vitamin K can be administered together with additional substances such as vitamin D.
    Type: Application
    Filed: March 11, 2020
    Publication date: September 17, 2020
    Inventors: Stefan CHLOPICKI, Katarzyna MARESZ
  • Publication number: 20200030258
    Abstract: A method for rapidly improving cardiovascular function, reducing arterial stiffness and reversing calcification of a blood vessel in a mammal comprising administering to the mammal an effective amount of vitamin K for a period of less than 6 months. Also a method for increasing endothelial nitric oxide production in mammals comprising administering to the mammal an effective amount of vitamin K for a period of less than 6 months. The vitamin K can be administered together with additional substances such as vitamin D.
    Type: Application
    Filed: August 27, 2019
    Publication date: January 30, 2020
    Inventors: Stefan Chlopicki, Katarzyna Maresz
  • Publication number: 20190328683
    Abstract: A method for rapidly improving cardiovascular function, reducing arterial stiffness and reversing calcification of a blood vessel in a mammal comprising administering to the mammal an effective amount of vitamin K for a period of less than 6 months. Also a method for increasing endothelial nitric oxide production in mammals comprising administering to the mammal an effective amount of vitamin K for a period of less than 6 months. The vitamin K can be administered together with additional substances such as vitamin D.
    Type: Application
    Filed: April 1, 2019
    Publication date: October 31, 2019
    Inventors: Stefan CHLOPICKI, Katarzyna MARESZ
  • Publication number: 20130230455
    Abstract: The invention relates to the use of gelsolin to treat neurologic diseases (e.g., multiple sclerosis) and to the use of gelsolin to diagnose, monitor, and evaluate therapies of neurologic diseases.
    Type: Application
    Filed: April 12, 2013
    Publication date: September 5, 2013
    Applicants: BloodCenter Research Foundation, Inc., THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
    Inventors: Thomas P. Stossel, Po-Shun Lee, Bonnie Dittel, Katarzyna Maresz
  • Patent number: 8440622
    Abstract: The invention relates to the use of gelsolin to treat neurologic diseases (e.g., multiple sclerosis) and to the use of gelsolin to diagnose, monitor, and evaluate therapies of neurologic diseases.
    Type: Grant
    Filed: March 14, 2007
    Date of Patent: May 14, 2013
    Assignees: The Brigham and Women's Hospital, Inc., BloodCenter Research Foundation, Inc.
    Inventors: Thomas P. Stossel, Po-Shun Lee, Bonnie Dittel, Katarzyna Maresz
  • Publication number: 20100021428
    Abstract: The invention relates to the use of gelsolin to treat neurologic diseases (e.g., multiple sclerosis) and to the use of gelsolin to diagnose, monitor, and evaluate therapies of neurologic diseases.
    Type: Application
    Filed: March 14, 2007
    Publication date: January 28, 2010
    Inventors: Thomas P. Stossel, Po-Shun Lee, Bonnie Dittel, Katarzyna Maresz